Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 8, 2018

View Archived Issues

Blood protein networks linked to complex diseases

Multigene assay constructed to predict late recurrence in ER-positive breast cancer

Suppressive role of exosomal TRIM3 in gastric cancer growth: potential biomarker and therapy target

First patients dosed in phase I/II study of FX-322

Salvensis patents compounds for schistosomiasis

Resverlogix announces seventh positive recommendation for phase III study of apabetalone

Korean researchers divulge new antiviral compounds

Data analysis completed for second cohort in part I of phase I/IIa study of CRV-431

U.S. researchers identify ITGA5 antagonists

NHRI synthesizes new CXCR4 ligands

Sichuan Kelun-Biotech Biopharmaceutical patents FXR agonists

Neuroendocrine stress pathways mediate the adverse health effects of air pollution

Plant-derived compound silvestrol inhibits HEV replication with additive effect to ribavirin

FDA expands approval of Orkambi to children 2 to 5 years of age

Researchers present new anti-CRH MAb for AD downstream pathologies

ADC Therapeutics begins dosing in registrational phase II trial evaluating ADCT-402

DMC recommends early continuation of phase III GENESIS study of BL-8040

Recruitment underway in TaiRx's phase II study of CMV-118 in combination with sorafenib

New sulfonamide is potent anti-breast cancer agent

Aged rhesus monkey shows same pattern of tau pathology as humans

Teneobio and Poseida to use UniDabs to develop CAR-T therapies

New biological target for Alzheimer's identified in BioArctic/Eisai collaboration

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.